BlackRock Health Sciences Term Trust (NYSE:BMEZ) Position Reduced by Truist Financial Corp

Truist Financial Corp trimmed its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 11.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,868 shares of the company’s stock after selling 2,482 shares during the period. Truist Financial Corp’s holdings in BlackRock Health Sciences Term Trust were worth $286,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Brown Brothers Harriman & Co. acquired a new position in BlackRock Health Sciences Term Trust during the third quarter valued at $32,000. K2 Principal Fund L.P. purchased a new position in BlackRock Health Sciences Term Trust during the 3rd quarter valued at about $158,000. Jane Street Group LLC acquired a new position in shares of BlackRock Health Sciences Term Trust in the 3rd quarter valued at about $357,000. Kingswood Wealth Advisors LLC purchased a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter worth approximately $420,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth approximately $471,000.

BlackRock Health Sciences Term Trust Stock Performance

BlackRock Health Sciences Term Trust stock opened at $15.69 on Thursday. BlackRock Health Sciences Term Trust has a 12 month low of $14.27 and a 12 month high of $16.75. The company’s fifty day simple moving average is $15.70 and its 200-day simple moving average is $15.67.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Monday, March 31st. Shareholders of record on Friday, March 14th will be given a $0.1763 dividend. The ex-dividend date of this dividend is Friday, March 14th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 13.48%.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.